JPMB:NYE-JPMorgan USD Emerging Markets Sovereign Bond ETF (USD)

ETF | Emerging Markets Bond |

Last Closing

USD 40.42

Change

-0.07 (-0.17)%

Market Cap

USD 0.61B

Volume

5.12K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of liquid, U.S. dollar-denominated sovereign and quasi-sovereign fixed and floating rate debt securities from emerging markets selected using a rules-based methodology that was developed and is owned by the adviser. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Emerging Markets Bond

Symbol Name Price(Change) Market Cap
PCY Invesco Emerging Markets Sover..

-0.09 (-0.42%)

USD 1.49B
HYEM VanEck Emerging Markets High Y..

+0.01 (+0.05%)

USD 0.40B

ETFs Containing JPMB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Bond) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.38% 33% F 29% F
Dividend Return 4.48% 33% F 73% C
Total Return 5.85% 33% F 34% F
Trailing 12 Months  
Capital Gain 10.84% 33% F 36% F
Dividend Return 6.63% 67% D+ 77% C+
Total Return 17.47% 33% F 41% F
Trailing 5 Years  
Capital Gain -20.65% 67% D+ 21% F
Dividend Return 17.89% 67% D+ 62% D
Total Return -2.76% 67% D+ 24% F
Average Annual (5 Year Horizon)  
Capital Gain -5.07% N/A N/A 15% F
Dividend Return -0.94% N/A N/A 19% F
Total Return 4.13% N/A N/A 72% C
Risk Return Profile  
Volatility (Standard Deviation) 9.74% N/A N/A 78% C+
Risk Adjusted Return -9.65% N/A N/A 18% F
Market Capitalization 0.61B 67% D+ 50% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike